Hanseatic Management Services’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,582	Closed	-$91K	–	112
2022 Q1	$91K	Buy	+5,582	New	+$91K	0.16%	62